IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.251
EU - Europa 1.650
AS - Asia 1.505
SA - Sud America 279
AF - Africa 15
OC - Oceania 2
Totale 5.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.188
SG - Singapore 605
IE - Irlanda 378
UA - Ucraina 370
HK - Hong Kong 260
BR - Brasile 243
CN - Cina 222
VN - Vietnam 210
RU - Federazione Russa 171
DE - Germania 162
IT - Italia 138
FI - Finlandia 126
SE - Svezia 104
KR - Corea 74
GB - Regno Unito 62
TR - Turchia 45
CA - Canada 40
BE - Belgio 26
FR - Francia 25
MX - Messico 21
AR - Argentina 15
IN - India 15
PL - Polonia 14
ES - Italia 13
BD - Bangladesh 11
CH - Svizzera 11
NL - Olanda 11
AT - Austria 9
JP - Giappone 9
CZ - Repubblica Ceca 8
LB - Libano 8
ID - Indonesia 7
UZ - Uzbekistan 7
GR - Grecia 6
IQ - Iraq 6
ZA - Sudafrica 6
EC - Ecuador 5
LT - Lituania 5
CL - Cile 4
CO - Colombia 4
PK - Pakistan 4
RO - Romania 4
BG - Bulgaria 3
PY - Paraguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
IL - Israele 2
JO - Giordania 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
DZ - Algeria 1
GA - Gabon 1
GH - Ghana 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PW - Palau 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TN - Tunisia 1
UY - Uruguay 1
YE - Yemen 1
Totale 5.702
Salva come PNG Salva come JPEG
Città #
Singapore 402
Chandler 383
Dublin 378
Hong Kong 260
Jacksonville 214
San Mateo 181
Dong Ket 157
Ashburn 104
Boardman 98
Ann Arbor 93
Santa Clara 85
Medford 77
Princeton 77
Munich 72
Beijing 64
Seoul 58
Wilmington 55
Moscow 50
Andover 48
Izmir 38
Helsinki 31
Perugia 30
São Paulo 28
Los Angeles 27
Ho Chi Minh City 25
Des Moines 24
Brussels 23
Saint Petersburg 21
New York 19
Piscataway 19
Turku 19
Ottawa 18
Altamura 17
Genoa 17
Brooklyn 15
Norwalk 15
Woodbridge 15
Dongjak-gu 14
Houston 13
London 12
Boston 11
Florence 11
Frankfurt am Main 11
Columbus 10
Lawrence 10
Redwood City 10
Shanghai 10
Stockholm 10
Orem 9
Tokyo 9
Warsaw 9
Hanoi 8
Mexico City 8
Montreal 8
Dallas 7
Ankara 6
Chicago 6
Denver 6
Manchester 6
Redmond 6
Toronto 6
Belo Horizonte 5
Chennai 5
Düsseldorf 5
Falls Church 5
Fortaleza 5
Guarulhos 5
Lauterbourg 5
Milan 5
Nuremberg 5
Olomouc 5
Porto Alegre 5
Seattle 5
Sorocaba 5
Amsterdam 4
Auburn Hills 4
Den Haag 4
Johannesburg 4
Portsmouth 4
Rio Grande 4
Rio de Janeiro 4
Rome 4
Secaucus 4
Viamão 4
Zhengzhou 4
Atlanta 3
Brasília 3
Buffalo 3
Calgary 3
Caxias do Sul 3
Corciano 3
Da Nang 3
Dearborn 3
Heusden 3
Itaquaquecetuba 3
Madrid 3
Poplar 3
Querétaro 3
San Francisco 3
San Jose 3
Totale 3.627
Salva come PNG Salva come JPEG
Nome #
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 129
" MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and elderly volunteers (winter season 2003/2004)" 124
"Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age" 4th National Congress of the Italian Society of Virology (SIV) 123
An influenza A/H3N2 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home 116
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 108
[Colony inhibition test (C.I.T.) and the cytotoxic adherence test (C.A.T.): some comparative data]. 106
Effect of age on serum heterologous antibody response elicited by inactivated influenza virus vaccine” 7th National Congress of the Italian Society of Virology 105
Annually repeated influenza vaccination and humoral response in elderly volunteers. 104
Immunogenicità ed efficacia protettiva del vaccino influenzale per l’inverno 2007/08 in soggetti anziani residenti in casa di riposo” 36° Congresso Nazionale della Società Italiana di Microbiologia 103
I benefici della vaccinazione influenzale Analisi e prospettive nella popolazione non anziana a rischio 100
An influenza B outbreak in elderly vaccinated people in the winter season 2007/2008” The Third European Influenza Conference 99
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 96
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 95
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 94
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 93
Influenza vaccination in patients on long-term anticoagulant therapy 93
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 92
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 92
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 89
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 88
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 86
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 86
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 86
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 84
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 83
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages 83
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 83
null 83
[Natural resistance and induced resistance to ATPC + tumor in mice]. 82
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 82
[The serum protein picture in mice with ATPC ascites tumors studied by means of disk electrophoresis]. 81
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 80
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 80
Proceedings of the X National Biotechnology Congress. 78
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 76
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 76
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 75
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 73
Cross-reactive antibodies to viruses of both B/Victoria and B/Yamagata lineages as induced by influenza vaccination in middle-aged and elderly volunteers 72
Immunization with adjuvanted and non-adjuvanted influenza vaccines of HIV-1 positive patients treated with highly active antiretroviral therapy (HAART) 72
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 72
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 72
Declined antibody response following influenza vaccination in elderly as compared with middle-aged volunteers: effects of aging and/or original antigenic sin? 70
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 69
Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility 69
[Selective inhibition of the response to the allograft of a virus in mice] 69
Influenza B virus circulation in elderly vaccinated people living in a nursing home in the winter season 2007/2008” 8th National Congress of the Italian Society of Virology 68
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 67
Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. 66
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 65
Induzione di anticorpi omologhi e cross-reattivi nei confronti di virus influenzali di tipo B da parte del vaccino influenzale nell'inverno 2003/2004 64
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 64
Synthesis and immuno-characterization of HSV-1 peptides for a potential vaccine 63
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 63
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 63
Serologically diagnosed influenza virus A/California/7/04 (H3N2)infection in people immunised with A/Fujan/411/2002(H3N2)antigen during the 2004/05 winter season 62
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 61
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 61
Twenty-seven years experience with immunogenicity of inactivated influenza vaccines in the elderly 61
Increased immunogenicity of an adjuvanted influenza vaccine compared with a conventional subunit vaccine in non-elderly adult HIV seropositive individuals, treated with HAART 59
Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. 58
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 56
Sorveglianza delle paralisi flaccide acute nella regione Umbria 56
Radioresistant Inhibition of Tumors (RIT): Biological and Pharmacological Studies 54
Factors influencing humoral immune response after influenza vaccination in elderly and very elderly subjects 54
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 53
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 53
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 53
Influenza A virus specific T cell immunity in humans during ageing 52
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 52
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 51
Soggetti ricoverati in ospedale in Umbria con diagnosi di laboratorio di infezione da virus influenzale pandemico A/H1N1 nel periodo Luglio 2009 - Marzo 2010 51
The new pandemic A/H1N1 influenza virus (pH1N1): celluler and humoral cross-reactive immune responses induced in healthy adults following 2007/2008 influenza vaccination. 50
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 50
Seroprevalence to the 2009 pandemic influenza a(H1N1) virus in the italian population after the 2009 pandemic (September/November 2010) 49
Influenza vaccination in patients on long-term anticoagulant therapy 45
Serological evidence of partial protection against infection with A/H3N2 circulating drifted strains after immunization with enhanced 2011/2012 trivalent influenza vaccines 43
A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60–85 years old) and very elderly (>85 years old) institutionalized subjects 5
Totale 5.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.989
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021402 0 0 0 0 0 23 74 3 65 14 61 162
2021/2022581 11 109 4 14 26 6 6 211 5 23 76 90
2022/20231.113 89 109 20 93 88 119 0 63 484 3 35 10
2023/2024483 32 45 30 9 3 1 125 28 71 4 86 49
2024/20251.144 15 114 31 59 181 38 46 36 223 78 196 127
2025/20261.062 167 149 84 281 282 99 0 0 0 0 0 0
Totale 5.843